MedTrace Logo

Multimodal Geriatric Pre-authorization Before Scheduled Orthopedic Surgery

NCT05062109 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2023-01-13

No results posted yet for this study

Summary

The main objective of this multicentric, prospective and interventional study is to assess the feasibility of multimodal prehabilitation in patients aged 75 years or older with surgical indication for coxarthrosis or severe gonarthrosis

Conditions

Interventions

BEHAVIORAL

Multimodal geriatric prehabilitation

Multimodal prehabilitation will be carried out over a period of 6 weeks in a day admission (once a week) and at home, and will include: * Muscle rehabilitation developed with a physiotherapist or physical activity monitor * Nutritional support (dietitian at the 1st, 3rd, and 6th day admission (DA)) * Cognitive and physical stimulation "Exergame" * Psychological support by a psychologist * Information in the form of videos on the main risks and important points to know and prepare before and after surgery * Assessment of patient satisfaction, any limitations encountered, the possible performance of exercises at home and the occurrence of any adverse effects. * One session of adapted physical activity at home of one hour per week by a physical trainer from the Siel Bleu association

Sponsors & Collaborators

  • Gérond'if

    lead OTHER

Principal Investigators

  • Jacques Boddaert, MD PhD · Geriatric Perioperative Unit, Pitié-Salpêtrière hospital

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-16
Primary Completion
2023-09-30
Completion
2023-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05062109 on ClinicalTrials.gov